List of COVID-19 vaccine authorizations

In 2025, at least 50 COVID-19 vaccines have received authorization in one or more countries — meaning they have been approved, licensed, or granted emergency use authorization by national regulatory authorities around the world in 201 country.

Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under assessment by the WHO: Sputnik V, Sinopharm WIBP, Abdala, Zifivax, Corbevax, COVIran Barekat, and SCB-2019.

Of the 50 vaccines, 16 have a full or emergency authorization in only one country, 12 in ten or fewer countries, and 12 in more than ten countries.

In some countries, vaccines may be authorized solely for travel purposes. They may not be approved for the general population. For example, the CoronaVac, Covishield, BBIBP-CorV and Covaxin vaccines are not part of Australia's national vaccination program; however, they are recognized for the purpose of travel to Australia.

Overview maps

Oxford–AstraZeneca The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria and Covishield, was a viral vector vaccine produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. Finland, Denmark, and Norway suspended the use of the Oxford–AstraZeneca vaccine due to a small number of reports of a rare blood clot disorder. Slovakia suspended its use after the death of a predisposed recipient. South Africa suspended its use because a small trial found only minimal protection against mild to moderate disease from the locally predominant Beta variant. Japan approved the vaccine for emergency use in May 2021, but did not plan to use them immediately because of rare cases of a blood clotting disorder reported overseas. Later, Japan started to use the vaccine for people aged 40 or over to mitigate the surge of the Delta variant in August. Finland ceased use of the vaccine as the last batch expired on 30 November 2021. Until then it was only offered for those aged 65 or more due to extremely rare coagulation disorders among younger recipients of the vaccine. After this Finland will not procure more of the vaccine. The AstraZeneca vaccine was the most widely accepted internationally, and the most popular in terms of total inoculated worldwide, over 1.3 billion. The AstraZeneca vaccine was administered in more countries than any other vaccine.

The vaccine is no longer in production. AstraZeneca withdrew its marketing authorizations for the vaccine from the European market in March 2024, and worldwide by May 2024.

Full (5) Australia Brazil Canada India Israel

Emergency (170) Afghanistan Albania Algeria Andorra Angola Argentina Armenia Azerbaijan Bahrain Bangladesh Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brunei Burkina Faso Cambodia Cameroon Cape Verde Central African Republic Chile Colombia Comoros Congo-Brazzaville Congo-Kinshasa Costa Rica Djibouti Dominican Republic East Timor Ecuador Egypt El Salvador Eswatini Ethiopia Fiji Gambia Georgia Ghana Guatemala Guinea-Bissau Guinea Honduras Indonesia Iran Iraq Ivory Coast Japan Jordan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Lebanon Lesotho Liberia Libya Madagascar Malawi Malaysia Maldives Mali Mauritania Mauritius Mexico Micronesia Moldova Mongolia Montenegro Morocco Mozambique Myanmar Namibia Public Notice No.: 05/032021 Nauru Nepal New Zealand Nicaragua Niger Nigeria North Macedonia Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Qatar Rwanda Samoa São Tomé and Príncipe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore (restricted) Solomon Islands Somalia South Korea South Sudan Sri Lanka Sudan Syria Taiwan Tajikistan Thailand Togo Tonga Tunisia Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom Uruguay Uzbekistan Vanuatu Vietnam Yemen Zambia Zimbabwe

Antigua and Barbuda Bahamas Barbados Belize Dominica Grenada Guyana Haiti Jamaica Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Suriname Trinidad and Tobago Anguilla Aruba British Virgin Islands Bermuda Caribbean Netherlands Cayman Islands Curaçao Montserrat Sint Maarten Turks and Caicos Islands Non-country entities Cook Islands Falkland Islands French Polynesia Greenland Guadeloupe Guernsey Isle of Man Jersey Northern Cyprus Pitcairn Saint Helena, Ascension and Tristan da Cunha Wallis and Futuna World Health Organization Travel-only Hong Kong Switzerland United States

Pfizer–BioNTech The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA vaccine produced by the German company BioNTech and the American company Pfizer. In Hong Kong, Macau, and Taiwan, Comirnaty is distributed by Fosun Pharma.

Original Full (39) Australia Brazil Canada Marshall Islands Micronesia New Zealand Palau Saudi Arabia Switzerland

Austria Belgium Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Italy Latvia Liechtenstein Lithuania Luxembourg Malta Netherlands Norway Poland Portugal Romania Slovakia Slovenia Spain Sweden Non-country entities Hong Kong Emergency (145) Afghanistan Albania Algeria Andorra Argentina Armenia Azerbaijan Bahrain Bangladesh Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brunei Cambodia Cameroon Cape Verde Chile China (For German citizens) Colombia Congo-Kinshasa Costa Rica Djibouti Dominican RepublicPfizer-BioNTech COVID-19 vaccine. Pan American Health Organization. East Timor Ecuador Egypt El Salvador Eswatini Fiji Gabon Georgia Ghana Guatemala Guinea Honduras Indonesia Iraq Israel Ivory Coast Japan Jordan Kazakhstan Kenya Kosovo Kuwait Kyrgyzstan Laos Lebanon Libya Malawi Malaysia Maldives Mexico Moldova Monaco Mongolia Montenegro Morocco Namibia Nepal Nicaragua Nigeria North Macedonia Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Qatar Rwanda Samoa San Marino Serbia Singapore Somalia South Africa South Korea Sri Lanka Sudan Syria Taiwan Tajikistan Tanzania Thailand Tonga Tunisia Turkey Uganda Ukraine United Arab Emirates United Kingdom Uruguay Uzbekistan Vatican City Vietnam Yemen Zambia

Non-country entities American Samoa Cook Islands Faroe Islands French Polynesia Gibraltar Greenland Guadeloupe Guam Guernsey Isle of Man Jersey Macau Martinique New Caledonia Niue Northern Cyprus Northern Mariana Islands Puerto Rico Tokelau World Health Organization

Bivalent original–BA.1 Japan

Bivalent original–BA.4/5

Canada China (For German citizens)

XBB.1.5 United States

JN.1 United Kingdom

KP.2 United States

Janssen The Janssen COVID-19 vaccine is a viral vector vaccine produced by Janssen Pharmaceutica (a subsidiary of Johnson & Johnson) and Beth Israel Deaconess Medical Center. It is also known as Johnson & Johnson COVID-19 Vaccine and as COVID-19 Vaccine Janssen. Three countries, Denmark, Finland, and Norway, discontinued the use of the Janssen vaccine in favor of other available vaccines due to a possible link between the vaccine and a rare blood clot disorder. The use of the Janssen adenovirus vector vaccine began in Finland in October 2021. It is only offered for those aged 65 and over because of a very rare risk of thrombosis in younger age groups. The United States began use of the Janssen vaccine in March 2021, but discouraged use in favor of other available vaccines in December 2021 due to the risk of a rare clotting disorder. The Janssen vaccine became unavailable in the United States in May 2023 after all existing doses expired.

Full (4) Australia (not used) Brazil Canada Switzerland

Emergency (132) Afghanistan Andorra Argentina Bahamas Bahrain Bangladesh Benin Bolivia Botswana Brunei Burkina Faso Cambodia Cameroon Central African Republic Chile Colombia Congo-Kinshasa Djibouti Egypt Eswatini Ethiopia Gabon Ghana Guinea Honduras India Indonesia Iran Iraq Ivory Coast Jordan Kenya Kuwait Laos Lebanon Lesotho Liberia Libya Madagascar Malawi Malaysia Maldives Mali Marshall Islands Mauritania Mexico Micronesia Moldova Monaco Morocco Mozambique Namibia Nepal New Zealand Nicaragua Nigeria Oman Pakistan Palau Palestine Papua New Guinea Peru Philippines Qatar Rwanda Saudi Arabia Senegal Singapore (restricted) Somalia South Africa South Korea South Sudan Sudan Syria Taiwan (not used) Tanzania Thailand Tunisia Uganda Ukraine United Arab Emirates United Kingdom United States (no longer available as of May 7, 2023 ) Vanuatu Vietnam Yemen Zambia Zimbabwe

Non-country entities American Samoa French Polynesia Greenland Guam New Caledonia Northern Cyprus Northern Mariana Islands Puerto Rico Africa Regulatory Taskforce World Health Organization Travel-only Hong Kong Japan Turkey

Moderna

List of COVID-19 vaccine authorizations

Bron en licentie